Biosimilars – Current Treatment – Biosimilar Target Product Profiles (Oncology)

The following figures show how the Target Product Profile Simulator can be used to create hypothetical market scenarios. We calculate preference share and prescribing likelihood for each therapy included in the example scenario based on part-worth utilities derived from surveyed medical oncologists’ responses in the ACBC module. In the scenario presented here, we limit our comparisons to three TPPs; the TPP Simulator can include up to seven user-defined TPPs.

launch Related Market Assessment Reports